Relative Strength Alert For DepoMed

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of DepoMed, Inc. ( DEPO) entered into oversold territory, hitting an RSI reading of 29.2, after changing hands as low as $10.29 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 49.5. A bullish investor could look at DEPO's 29.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of DEPO shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

DepoMed, Inc. 1 Year Performance Chart

Looking at the chart above, DEPO's low point in its 52 week range is $4.99 per share, with $15.39 as the 52 week high point — that compares with a last trade of $10.65.

According to the ETF Finder at ETF Channel, DEPO makes up 2.63% of the PowerShares Dynamic Pharmaceuticals Portfolio ETF ( PJP) which is trading lower by about 0.9% on the day Friday.

If you liked this article you might like

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed

Depomed Focuses on Flagship Drug Rather Than M&A: CEO